Blood Stem Cell Transplant With Low Dose Chemotherapy for Relapsed Follicular Non-Hodgkin's Lymphoma (BMT CTN 0701)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mary Horowitz, MD, MS
Center for International Blood and Marrow Transplant Research (CIBMTR), Medical College of Wisconsin
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
21 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- City of Hope National Medical Center
Duarte, California, United States
- University of California, San Diego (ucsd) Medical Center
La Jolla, California, United States
- University of California, Davis Medical Center
Sacramento, California, United States
- Stanford Hospital and Clinics
Stanford, California, United States
- University of Florida College of Medicine
Gainesville, Florida, United States
- H. Lee Moffitt Cancer Center
Tampa, Florida, United States
- Rush University Medical Center
Chicago, Illinois, United States
- Dana-Farber Cancer Institute (dfci)/brigham & Women'S Hospital
Boston, Massachusetts, United States
- Dana-Farber Cancer Institute (dfci)/massachusetts General Hospital
Boston, Massachusetts, United States
- University of Minnesota
Minneapolis, Minnesota, United States
- University of Nebraska Medical Center
Omaha, Nebraska, United States
- University of North Carolina Hospital at Chapel Hill
Chapel Hill, North Carolina, United States
- Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States
- University Hospitals of Cleveland/case Western
Cleveland, Ohio, United States
- Ohio State/arthur G. James Cancer Hospital
Columbus, Ohio, United States
- University of Oklahoma Medical Center
Oklahoma City, Oklahoma, United States
- Vanderbilt University Medical Center
Nashville, Tennessee, United States
- University of Texas, Md Anderson Cancer Research Center
Houston, Texas, United States
- West Virginia University
Morgantown, West Virginia, United States
- University of Wisconsin Hospital and Clinics
Madison, Wisconsin, United States
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2009
- Primary completion
- 30 Nov 2014
- Completion
- 31 Aug 2016
- Last update posted
- 9 Dec 2022
- Registered enrollment
- 65
- Registry id
- NCT00912223
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.